|
CN111285914A
|
|
Preparation method of obeticholic acid
|
|
WO2019037742A1
|
|
Imidazolone androgen receptor antagonist, preparation method therefor and use thereof
|
|
EP3626723A4
|
|
Intermediate of eribulin and preparation method therefor
|
|
WO2018202202A1
|
|
Compound with kinase inhibitory activity and preparation method and use thereof
|
|
WO2018196812A1
|
|
Boric acid and borate ester compound, and preparation method and use therefor
|
|
CN110156971A
|
|
A kind of amphipathic nature block polymer and preparation method thereof and nano-micelle drug-loading system
|
|
CN109400517A
|
|
1- methyl-tryptophan class compound and its preparation method and application
|
|
CN109280054A
|
|
Deuterated 3- quinuclidine ketone compounds, Preparation method and use
|
|
CN109280056A
|
|
Chiral 3- quinuclidine ketone compounds, Preparation method and use
|
|
CN109206380A
|
|
Indoleamine 2,3-dioxygenase inhibitor compound and its preparation method and application
|
|
CN109081828A
|
|
Poly- (ADP- ribose) polymerase inhibitors, Preparation method and use
|
|
CN108727190A
|
|
The preparation method of intermediate of salviandic acid A and preparation method thereof and salviandic acid A
|
|
CN108689795A
|
|
A kind of intermediate and preparation method thereof being used to prepare eribulin
|
|
CN108659031A
|
|
A kind of intermediate and preparation method thereof being used to prepare eribulin
|
|
CN108658956A
|
|
Eribulin intermediate and preparation method thereof
|
